Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 401-410 of 682 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance Of Intermediate Risk Prostate Cancer

    Rochester, MN

  2. Schedule De-Escalation Of 177Lu-PSMA-617 For The Treatment Of Metastatic Castrate Resistant Prostate Cancer

    Rochester, MN

  3. Stereotactic Adaptive Radiation Therapy Of Borderline Resectable Pancreatic Cancer An Individualized Approach

    Rochester, MN

  4. A Study Of Obesity And Inflammation Impact Immunotherapy For Renal Cancer

    Scottsdale/Phoenix, AZ

  5. A Study Of Strengthening Teen Brain Resilience Using Music For Cancer Treatment

    Scottsdale/Phoenix, AZ

  6. Offering HPV Self-Collection In Novel Healthcare Settings To Improve Uptake Of Cervical Cancer Screening

    Rochester, MN

  7. Phase 1 Study Of CLR 125 In Triple Negative Breast Cancer

    Jacksonville, FL, Rochester, MN

  8. A First-in-Human Study Of MEN2501 In Participants With Platinum-Resistant Ovarian Cancer

    Rochester, MN

  9. Zunsemetinib In Combination With Capecitabine In Patients With Hormone Receptor-Positive And HER2-Negative Metastatic Breast Cancer With Bone Metastasis

    Rochester, MN

  10. Study Of STK-012 Alone And With Other Treatments In Patients With Advanced Lung Cancer And Other Cancers

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer